T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation with Busulfan, Melphalan, and Fludarabine Conditioning Followed by Post Transplantation Donor Lymphocyte Infusions for Patients with Relapsed Multiple Myeloma and High-Risk Cytogenetics

Guenther Koehne; Heather Landau; Hani Hassoun; Alex Lesokhin; Nikoletta Lendvai; Michael A. Rosenzweig; Glenn Heller; Sergio Giralt

T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation with Busulfan, Melphalan, and Fludarabine Conditioning Followed by Post Transplantation Donor Lymphocyte Infusions for Patients with Relapsed Multiple Myeloma and High-Risk Cytogenetics

Guenther Koehne, Heather Landau, Hani Hassoun, Alex Lesokhin, Nikoletta Lendvai, Michael A. Rosenzweig, Glenn Heller, Sergio Giralt

Miami Cancer Institute

Research output: Contribution to conference › Presentation

Original language	American English
State	Published - Nov 18 2011
Event	Blood - Duration: Jan 1 2020 → …

Conference

Conference	Blood
Period	1/1/20 → …

Disciplines

Medicine and Health Sciences
Immunology and Infectious Disease

Cite this

Koehne, G., Landau, H., Hassoun, H., Lesokhin, A., Lendvai, N., Rosenzweig, M. A., Heller, G., & Giralt, S. (2011). T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation with Busulfan, Melphalan, and Fludarabine Conditioning Followed by Post Transplantation Donor Lymphocyte Infusions for Patients with Relapsed Multiple Myeloma and High-Risk Cytogenetics. Blood.

T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation with Busulfan, Melphalan, and Fludarabine Conditioning Followed by Post Transplantation Donor Lymphocyte Infusions for Patients with Relapsed Multiple Myeloma and High-Risk Cytogenetics. / Koehne, Guenther; Landau, Heather; Hassoun, Hani et al.
2011. Blood.

Research output: Contribution to conference › Presentation

Koehne, G, Landau, H, Hassoun, H, Lesokhin, A, Lendvai, N, Rosenzweig, MA, Heller, G & Giralt, S 2011, 'T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation with Busulfan, Melphalan, and Fludarabine Conditioning Followed by Post Transplantation Donor Lymphocyte Infusions for Patients with Relapsed Multiple Myeloma and High-Risk Cytogenetics', Blood, 1/1/20.

@conference{93988dd770fc477eacfb81e6119b3891,

title = "T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation with Busulfan, Melphalan, and Fludarabine Conditioning Followed by Post Transplantation Donor Lymphocyte Infusions for Patients with Relapsed Multiple Myeloma and High-Risk Cytogenetics",

author = "Guenther Koehne and Heather Landau and Hani Hassoun and Alex Lesokhin and Nikoletta Lendvai and Rosenzweig, {Michael A.} and Glenn Heller and Sergio Giralt",

note = "Abstract 1992 Allogeneic hematopoietic stem cell transplantation (allo HSCT) is a curative therapy for patients (pts) with multiple myeloma, but conventional allo HSCT has been associated with unacceptably high rates of mortality. Non-myeloablative allo HSCT has resulted in high rates of acute and chronic graft-versus-host disease (GvHD) and progression.; Blood ; Conference date: 01-01-2020",

year = "2011",

month = nov,

day = "18",

language = "American English",

}

TY - CONF

T1 - T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation with Busulfan, Melphalan, and Fludarabine Conditioning Followed by Post Transplantation Donor Lymphocyte Infusions for Patients with Relapsed Multiple Myeloma and High-Risk Cytogenetics

AU - Koehne, Guenther

AU - Landau, Heather

AU - Hassoun, Hani

AU - Lesokhin, Alex

AU - Lendvai, Nikoletta

AU - Rosenzweig, Michael A.

AU - Heller, Glenn

AU - Giralt, Sergio

N1 - Abstract 1992 Allogeneic hematopoietic stem cell transplantation (allo HSCT) is a curative therapy for patients (pts) with multiple myeloma, but conventional allo HSCT has been associated with unacceptably high rates of mortality. Non-myeloablative allo HSCT has resulted in high rates of acute and chronic graft-versus-host disease (GvHD) and progression.

PY - 2011/11/18

Y1 - 2011/11/18

UR - http://www.bloodjournal.org/content/118/21/1992?sso-checked=true

M3 - Presentation

T2 - Blood

Y2 - 1 January 2020

ER -

T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation with Busulfan, Melphalan, and Fludarabine Conditioning Followed by Post Transplantation Donor Lymphocyte Infusions for Patients with Relapsed Multiple Myeloma and High-Risk Cytogenetics

Conference

Disciplines

Other files and links

Cite this